Evidence map›Paper›PMID 41599758›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Discovery of New Quinazolinone and Benzimidazole Analogs as Tubulin Polymerization Inhibitors with Potent Anticancer Activities.

Boye Jiang, Juan Zhang, Kai Shao, Conghao Gai, Bing Xu, Yan Zou, Yan Song, Qingjie Zhao, Qingguo Meng, Xiaoyun Chai

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Boye JiangDepartment of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China.
Juan ZhangPLA Naval Medical Center, Second Military Medical University, Shanghai 200052, China.
Kai ShaoDepartment of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China.
Conghao GaiDepartment of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China.ORCID 0000-0001-6760-5045
Bing XuDepartment of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China.
Yan ZouDepartment of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China.
Yan SongPLA Naval Medical Center, Second Military Medical University, Shanghai 200052, China.
Qingjie ZhaoDepartment of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China.
Qingguo MengSchool of Pharmacy, Yantai University, Yantai 264005, China.
Xiaoyun ChaiDepartment of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China.ORCID 0000-0001-9688-9091

Funding

National Natural Science Foundation of China NO. 82204347, 82473778Undergraduate Student Innovation and Practice Incubation Base Project of Naval Medical University FH2024166
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anticancer activitymolecular hybridizationtubulin

Identifiers

PMID41599758
PMCPMC12844652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.